Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations

Publikation: Beitrag in FachzeitschriftKommentar (Comment) / Leserbriefe ohne eigene DatenBeigetragenBegutachtung

Beitragende

  • Hartmut Döhner - , Universitätsklinikum Ulm (Autor:in)
  • Courtney D DiNardo - , University of Texas MD Anderson Cancer Center (Autor:in)
  • Frederick R Appelbaum - , University of Washington, Fred Hutchinson Cancer Research Center (Autor:in)
  • Charles Craddock - , University of Warwick, University Hospitals Birmingham NHS Foundation Trust (Autor:in)
  • Hervé Dombret - , Hôpital Saint-Louis AP-HP (Autor:in)
  • Benjamin L Ebert - , Dana-Farber Cancer Institute (Autor:in)
  • Pierre Fenaux - , Hôpital Saint-Louis AP-HP (Autor:in)
  • Lucy A Godley - , Northwestern University (Autor:in)
  • Robert P Hasserjian - , Boston Children's Hospital (Autor:in)
  • Richard A Larson - , The University of Chicago (Autor:in)
  • Ross L Levine - , Memorial Sloan-Kettering Cancer Center (Autor:in)
  • Yasushi Miyazaki - , Nagasaki University (Autor:in)
  • Dietger Niederwieser - , Universitätsklinikum Leipzig (Autor:in)
  • Gert Ossenkoppele - , Amsterdam University Medical Centers (UMC) (Autor:in)
  • Christoph Röllig - , Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Jorge Sierra - , Hospital de la Santa creu i Sant Pau (Autor:in)
  • Eytan M Stein - , Memorial Sloan-Kettering Cancer Center (Autor:in)
  • Martin S Tallman - , Memorial Sloan-Kettering Cancer Center (Autor:in)
  • Hwei-Fang Tien - , National Taiwan University Hospital (Autor:in)
  • Jianxiang Wang - , Chinese Academy of Medical Sciences, Peking Union Medical College (Autor:in)
  • Agnieszka Wierzbowska - , Medical University of Łódź (Autor:in)
  • Andrew H Wei - , Royal Melbourne Hospital (Autor:in)
  • Bob Löwenberg - , Erasmus University Medical Center (Autor:in)

Abstract

The European LeukemiaNet (ELN) genetic risk classifications were developed based on data from younger adults receiving intensive chemotherapy. Emerging analyses from patients receiving less-intensive therapies prompted a proposal for an ELN genetic risk classification specifically for this patient population.

Details

OriginalspracheEnglisch
Seiten (von - bis)2169-2173
Seitenumfang5
FachzeitschriftBlood
Jahrgang144
Ausgabenummer21
PublikationsstatusVeröffentlicht - 21 Nov. 2024
Peer-Review-StatusJa

Externe IDs

Scopus 85203490901

Schlagworte

Schlagwörter

  • Humans, Leukemia, Myeloid, Acute/genetics, Adult, Risk Assessment, Genetic Predisposition to Disease, Risk Factors